Bicycle Therapeutics plc Current Federal Tax Expense (Benefit)
Bicycle Therapeutics plc (BCYC) reported Current Federal Tax Expense (Benefit) of $283.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2025-02-25
- Bicycle Therapeutics plc current federal tax expense (benefit) for fiscal 2024 was $283.00K.
- Bicycle Therapeutics plc current federal tax expense (benefit) for fiscal 2023 was -$1.18M, a 157.62% decline from fiscal 2022.
- Bicycle Therapeutics plc current federal tax expense (benefit) for fiscal 2022 was $2.05M.
- Bicycle Therapeutics plc current federal tax expense (benefit) for fiscal 2021 was -$2.00K.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $283.00K 10-K · filed 2025-02-25 |
| 2023-12-31 | -$1.18M 10-K · filed 2025-02-25 |
| 2022-12-31 | $2.05M 10-K · filed 2025-02-25 |
| 2021-12-31 | -$2.00K 10-K · filed 2024-02-20 |
| 2020-12-31 | -$24.00K 10-K · filed 2023-02-28 |
| 2019-12-31 | $49.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | -$25.00K 10-K · filed 2021-03-11 |
| 2017-12-31 | $75.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |